Article 51 LFSS 2018
Type of financing
Experimentation
Beneficiary
Medical device manufacturer
Context of use
Facility / City
Purpose of the system
Encourage, support and accelerate the deployment of innovative experimental healthcare organizations based on novel financing methods that depart from many common law rules.
.These experiments are applicable in the city as well as in hospital establishments or the medico-social sector, and aim to promote "pathway pricing" approaches and thus help to decompartmentalize the French healthcare system by encouraging cooperation between players.
Issues
Legal framework aimed at experimenting with and financing innovative organizations based on innovative financing methods favoring "route-based pricing" approaches.
Is this scheme right for my project?
Eligible are experiments involving innovation in healthcare pathway coordination, the relevance and quality of healthcare, social or medico-social care, the structuring of ambulatory care and access to care.
It does not allow experimentation with a technological device alone, and does not constitute early access to the market.
Type of financing
- Tarification, pay as you go.
Location of financing
- National (funding via FISS): Fonds pour l'innovation du système de santé, managed by the CNAM and dedicated to the financing of derogatory services for regional and national projects and the engineering of national projects, the evaluation of experiments (carried out by external service providers);
- Regional (financed via the FIR): Fonds d'Intervention Régionale (Regional Intervention Fund), in the hands of the ARS, it covers seed funding and engineering for regional projects Article 51 (These are funds intended to cover non-permanent costs incurred by the "good start" of the experiment, not covered by the derogatory services. Seed funding is used to finance costs relating to the project's ramp-up phase, while engineering funding (CI) is used to finance additional costs relating to setting up and managing the project.
Amount of financing
The amount of funding depends on each experimental project, and must be detailed and justified in a financing plan (a financial table showing all the project's financial information). It is carefully studied by the Comité Technique de l'Innovation en Santé (CTIS).
Calendar / periodicity
Projects can be submitted as they come in on the platform of the ARS concerned or on that of the Ministry of Solidarity and Health, depending on the territorial scope.
Carrier type
- Collaborative project.
- The project is open to all players in the healthcare system:
- User associations, healthcare establishments (public or private), federations and unions, healthcare professionals, companies, homecare professionals, complementary organizations or local authorities can be project carriers - no restrictions on the legal status of project carriers.
Conditions to be met
- Receivability (purpose and need for derogation from common law)
- Innovative character
- Feasibility
- Reproducibility for dissemination
- Ratio quality/price (efficiency)
How to apply
- Via the national filing platform for projects concerning several regions.
- Via a regional filing platform for projects concerning a single region.
Consult the list of regional referents.
Find all the information you need to apply on the you have a project page.
Practical guide
All the questions you need to ask yourself, to tackle Article 51 properly.